Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

113.38 -1.16 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,429,495
Open 114.29
Bid (Size) 111.50 (2)
Ask (Size) 113.50 (1)
Prev. Close 114.54
Today's Range 111.86 - 114.58
52wk Range 74.75 - 142.00
Shares Outstanding 96,748,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact. 
Via InvestorPlace

Performance

YTD
-7.89%
-7.89%
1 Month
-11.17%
-11.17%
3 Month
-17.80%
-17.80%
6 Month
-8.63%
-8.63%
1 Year
-11.38%
-11.38%

More News

Read More
Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
Via InvestorPlace
Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
Via Benzinga
Peering Into DexCom's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today
Via Benzinga
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
The 3 Best Diabetes Stocks to Buy in June 2024
Via InvestorPlace
What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
Via Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
In-Depth Examination Of 6 Analyst Recommendations For DexCom
Via Benzinga
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Via Chartmill
Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
Via Benzinga
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
From Dexcom, Inc.
Via Business Wire
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Via The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
From Tandem Diabetes Care, Inc.
Via Business Wire
3 Growth Stocks the New ‘GPT-4o’ AI Bot Says Will Make You Rich
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Google Parent Alphabet Is Selling Shares of 2 Hypergrowth Stocks and Piling Into a Promising Artificial Intelligence (AI) Company
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.